InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425
$86.01 +5.73% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $86.01 +399.19% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 18 Jul 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−54.7Net income−52.6Fiscal year 2020Revenue0.0Operating income−104.3Net income−103.3Fiscal year 2021Revenue19.1Operating income−173.4Net income−84.0EPS, diluted−2.77Fiscal year 2022Revenue77.1 +302.7%Operating income−131.2Net income−135.7EPS, diluted−4.02Fiscal year 2023Revenue186.4 +141.8%Operating income−109.2Net income−163.4EPS, diluted−4.00Fiscal year 2024Revenue336.9 +80.8%Operating income−87.6Net income−87.9EPS, diluted−1.85Fiscal year 2025Revenue521.3 +54.7%Operating income−22.1Net income−23.4EPS, diluted−0.47
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.0 19.1 77.1 186.4 336.9 521.3
Growth +302.7% +141.8% +80.8% +54.7%
Operating income −54.7 −104.3 −173.4 −131.2 −109.2 −87.6 −22.1
Net income −52.6 −103.3 −84.0 −135.7 −163.4 −87.9 −23.4
Growth
EPS, diluted n/a n/a −2.77 −4.02 −4.00 −1.85 −0.47
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Fiscal year 2020Fiscal year 2021Operating margin−906.1%Net margin−438.9%Free cash flow margin−693.8%Fiscal year 2022Operating margin−170.3%Net margin−176.0%Free cash flow margin−156.3%Fiscal year 2023Operating margin−58.6%Net margin−87.7%Free cash flow margin−38.1%Fiscal year 2024Operating margin−26.0%Net margin−26.1%Free cash flow margin2.8%Fiscal year 2025Operating margin−4.2%Net margin−4.5%Free cash flow margin10.5%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −906.1% −170.3% −58.6% −26.0% −4.2%
Net margin n/a n/a −438.9% −176.0% −87.7% −26.1% −4.5%
Free cash flow margin n/a n/a −693.8% −156.3% −38.1% 2.8% 10.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−39.4Capital expenditure−0.3Free cash flow−39.6Fiscal year 2020Operating cash flow−89.1Capital expenditure−0.2Free cash flow−89.3Fiscal year 2021Operating cash flow−132.8Capital expenditure−0.0Free cash flow−132.8Fiscal year 2022Operating cash flow−120.1Capital expenditure−0.3Free cash flow−120.4Fiscal year 2023Operating cash flow−70.9Capital expenditure−0.1Free cash flow−71.1Fiscal year 2024Operating cash flow10.3Capital expenditure−1.0Free cash flow9.3Fiscal year 2025Operating cash flow55.8Capital expenditure−1.0Free cash flow54.9 +488.0%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −39.4 −89.1 −132.8 −120.1 −70.9 10.3 55.8
Capital expenditure −0.3 −0.2 −0.0 −0.3 −0.1 −1.0 −1.0
Free cash flow −39.6 −89.3 −132.8 −120.4 −71.1 9.3 54.9
Growth +488.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash12.0Shareholders’ equity130.3Fiscal year 2020Cash142.1Shareholders’ equity172.1Fiscal year 2021Cash31.3Shareholders’ equity120.2Fiscal year 2022Cash28.0Shareholders’ equity142.0Fiscal year 2023Cash286.3Shareholders’ equity248.7Fiscal year 2024Cash222.5Shareholders’ equity225.6Fiscal year 2025Cash296.7Shareholders’ equity314.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.0 142.1 31.3 28.0 286.3 222.5 296.7
Shareholders’ equity 130.3 172.1 120.2 142.0 248.7 225.6 314.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 0.0 19.1 77.1 186.4 336.9 521.3
Growth +302.7% +141.8% +80.8% +54.7%
11.8 22.7 59.2 89.1 145.9 202.2 257.0
−54.7 −104.3 −173.4 −131.2 −109.2 −87.6 −22.1
Growth
−52.5 −103.3 −84.0 −142.1 −162.4 −86.9 −21.4
0.0 0.0 0.0 −6.4 1.0 1.0 1.9
−52.6 −103.3 −84.0 −135.7 −163.4 −87.9 −23.4
Growth
Per share
n/a n/a −2.77 −4.01 −4.00 −1.85 −0.47
n/a n/a −2.77 −4.02 −4.00 −1.85 −0.47
Growth
n/a n/a 30.3 33.8 40.9 47.5 50.2
n/a n/a 30.3 34.0 40.9 47.5 50.2
Growth +12.1% +20.3% +16.2% +5.6%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 7 years on file.